Literature DB >> 25875390

Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.

Kadir Ozturk1, Ahmet Uygun2, Ahmet Kerem Guler3, Hakan Demirci2, Cafer Ozdemir4, Mehmet Cakir3, Yusuf Serdar Sakin2, Turker Turker5, Sebahattin Sari6, Seref Demirbas3, Yıldırım Karslıoğlu7, Mutlu Saglam6.   

Abstract

INTRODUCTION: The possible cause of accelerated atherosclerosis in NAFLD may be the relationship with the MetS and its components. Our primary goal was to evaluate the relationship between NAFLD and subclinical atherosclerosis in adult male patients between 20 and 40 years of age. Moreover, we aimed to investigate the changes in this association according to the presence or absence of MetS.
METHOD: Sixty-one male patients with biopsy-proven NAFLD and 41 healthy male volunteers were enrolled. In order to exclude any interference of confounding factors, we studied a specifically selected group with no additional cardiovascular risk. PWV, CIMT and FMD levels were measured in all patients and controls.
RESULTS: The levels of cf-PWV were significantly higher in SS and NASH patients compared to the control group (P < 0.001); no significant difference was found between SS and NASH patients (P > 0.05). We found significantly decreased FMD levels in patients with SS and NASH compared with control subjects (P < 0.001). Subjects with NASH had significantly greater CIMT measurements than the SS and controls (P = 0.026, P < 0.001, respectively). Although, NAFLD patients with MetS had increased cf-PWV and CIMT and reduced FMD compared to healthy subjects (P < 0.05), no significant difference existed between NAFLD with Mets and NAFLD without MetS in terms of cf-PWV, CIMT and FMD (P > 0.05)
CONCLUSION: The present study showed that the presence of NAFLD leads to increased risk of endothelial dysfunction and atherosclerosis in adult male patients, independent of MetS.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arterial stiffness; Carotid intima media thickness; Flow mediated dilatation; Nonalcoholic fatty liver disease

Mesh:

Year:  2015        PMID: 25875390     DOI: 10.1016/j.atherosclerosis.2015.04.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  22 in total

Review 1.  Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management.

Authors:  Alexandra Jichitu; Simona Bungau; Ana Maria Alexandra Stanescu; Cosmin Mihai Vesa; Mirela Marioara Toma; Cristiana Bustea; Stela Iurciuc; Marius Rus; Nicolae Bacalbasa; Camelia Cristina Diaconu
Journal:  Diagnostics (Basel)       Date:  2021-04-12

Review 2.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

Review 3.  Non-alcoholic fatty liver disease: A growing public health problem in Turkey.

Authors:  Eda Kaya; Yusuf Yılmaz
Journal:  Turk J Gastroenterol       Date:  2019-10       Impact factor: 1.852

4.  Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.

Authors:  Ansel Shao Pin Tang; Kai En Chan; Jingxuan Quek; Jieling Xiao; Phoebe Tay; Margaret Teng; Keng Siang Lee; Snow Yunni Lin; May Zin Myint; Benjamin Tan; Vijay K Sharma; Darren Jun Hao Tan; Wen Hui Lim; Apichat Kaewdech; Daniel Huang; Nicholas Ws Chew; Mohammad Shadab Siddiqui; Arun J Sanyal; Mark Muthiah; Cheng Han Ng
Journal:  Clin Mol Hepatol       Date:  2022-03-02

Review 5.  NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?

Authors:  Cristiane A Villela-Nogueira; Nathalie C Leite; Claudia R L Cardoso; Gil F Salles
Journal:  Int J Mol Sci       Date:  2016-04-20       Impact factor: 5.923

6.  External validation of non-invasive prediction models for identifying ultrasonography-diagnosed fatty liver disease in a Chinese population.

Authors:  Ya-Nan Shen; Ming-Xing Yu; Qian Gao; Yan-Yan Li; Jian-Jun Huang; Chen-Ming Sun; Nan Qiao; Hai-Xia Zhang; Hui Wang; Qing Lu; Tong Wang
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

7.  The prevalence and risk factors of young male schizophrenics with non-alcoholic fatty liver disease.

Authors:  Jing Yan; Chengye Hou; Ying Liang
Journal:  Neuropsychiatr Dis Treat       Date:  2017-06-12       Impact factor: 2.570

Review 8.  Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis.

Authors:  Xin Xu; Linlin Lu; Quanyong Dong; Xiaolin Li; Nannan Zhang; Yongning Xin; Shiying Xuan
Journal:  Lipids Health Dis       Date:  2015-12-03       Impact factor: 3.876

9.  In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter.

Authors:  Theodor Baars; Ursula Neumann; Mona Jinawy; Stefanie Hendricks; Jan-Peter Sowa; Julia Kälsch; Mona Riemenschneider; Guido Gerken; Raimund Erbel; Dominik Heider; Ali Canbay
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

10.  Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Kadir Ozturk; Omer Kurt; Tolga Dogan; Alptug Ozen; Hakan Demirci; Fatih Yesildal; Murat Kantarcioglu; Turker Turker; Ahmet Kerem Guler; Yıldırım Karslioglu; Battal Altun; Ahmet Uygun; Sait Bagci
Journal:  Gastroenterol Res Pract       Date:  2016-02-22       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.